- Clinical Management of Ocular Surface Squamous Neoplasia: A Review of the Current Evidence
Maria Vittoria Cicinelli et al, 2018, Ophthalmology and Therapy CrossRef - Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer
Paal F. Brunsvig et al, 2020, Frontiers in Immunology CrossRef - Telomeres, Telomerase and Ageing
Gabriele Saretzki, 2018, Biochemistry and Cell Biology of Ageing: Part I Biomedical Science CrossRef - Rapid and dramatic responses to dabrafenib and trametinib in BRAF V600E‐mutated lung adenocarcinoma
Takayo Ota et al, 2021, Respirology Case Reports CrossRef - Primary tumor type prediction based on US nationwide genomic profiling data in 13,522 patients
Yunru Huang et al, 2023, Computational and Structural Biotechnology Journal CrossRef - Pan-cancer analyses confirmed the cuproptosis-related gene FDX1 as an immunotherapy predictor and prognostic biomarker
Chi Zhang et al, 2022, Frontiers in Genetics CrossRef - Coexistence of TERT Promoter Mutations and the BRAF V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients
Dagmara Rusinek et al, 2018, International Journal of Molecular Sciences CrossRef - Telomere Maintenance Mechanisms in Cancer
Tiago Bordeira Gaspar et al, 2018, Genes CrossRef - AAV9-mediated telomerase activation does not accelerate tumorigenesis in the context of oncogenic K-Ras-induced lung cancer
Miguel A. Muñoz-Lorente et al, 2018, PLOS Genetics CrossRef - Immortalized normal human lung epithelial cell models for studying lung cancer biology
Mitsuo Sato et al, 2020, Respiratory Investigation CrossRef - Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival
Neil Mundi et al, 2019, Cancers of the Head & Neck CrossRef - Absence of Clinical Value of TZAP Mutation and Expression in Non-small Cell Lung Cancers
Deok Heon Lee et al, 2020, Keimyung Medical Journal CrossRef - Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901)
Wenying Peng et al, 2022, The Oncologist CrossRef - Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes
Alessandro Di Federico et al, 2022, Cancers CrossRef - Accumulation of plasmacytoid dendritic cell is associated with a treatment response to DNA-damaging treatment and favorable prognosis in lung adenocarcinoma
Yoon Jin Cha et al, 2023, Frontiers in Immunology CrossRef - Dysregulation of Cis-Regulatory Elements in Cancer
Jayne A. Barbour et al, 2019, Clinical Epigenetics CrossRef - Tumorigenic effect of TERT and its potential therapeutic target in NSCLC (Review)
Liu Yang et al, 2021, Oncology Reports CrossRef - Human telomerase reverse transcriptase and telomeres in cancer
Anurag Mehta et al, 2021, Journal of Current Oncology CrossRef - TERT Mutations in Non–Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Implications
Liu Yang et al, 2023, Clinical Medicine Insights: Oncology CrossRef - Spindle component 25 predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis
Fengjuan Xia et al, 2024, Scientific Reports CrossRef - Telomere Length and Lung Cancer Mortality among Heavy Smokers
Jennifer A. Doherty et al, 2018, Cancer Epidemiology, Biomarkers & Prevention CrossRef - Prognostic significance of human telomerase reverse transcriptase promoter region mutations C228T and C250T for overall survival in spinal chordomas
Chetan Bettegowda et al, 2019, Neuro-Oncology CrossRef - Prognostic Value of Telomeric Zinc Finger-Associated Protein Expression in Adenocarcinoma and Squamous Cell Carcinoma of Lung
Gun-Jik Kim et al, 2021, Medicina CrossRef - Different Role of TRF1 and TRF2 Expression in Non-Small Cell Lung Cancers
Mincheol Chae et al, 2024, OncoTargets and Therapy CrossRef